发明名称 |
Diagnosis and monitoring of lung cancer patients by measurement of NCA 50/90 in blood |
摘要 |
A method for aiding in the diagnosis of, and monitoring the progression or course of, lung cancer in a patient by measuring the amount of NCA 50/90 in a blood sample, e.g., serum sample, obtained from the patient. Measurement in a single sample of an amount of NCA 50/90 significantly higher than the mean amount of NCA 50/90 in the normal population is an indication of lung cancer in a symptomatic patient. The course of lung cancer can also be monitored by performing a series of specific immunoassays over time to determine changes in the level of NCA 50/90 in blood samples. Increases in blood NCA 50/90 levels over time are indicative of a deteriorating condition whereas decreasing levels of blood NCA 50/90 over time indicate an improving condition.
|
申请公布号 |
US5605804(A) |
申请公布日期 |
1997.02.25 |
申请号 |
US19950400152 |
申请日期 |
1995.03.07 |
申请人 |
BAYER CORPORATION |
发明人 |
ALLARD, WILLIAM J.;YEUNG, KWOK K. |
分类号 |
C12N15/02;C12P21/08;C12R1/91;G01N33/53;G01N33/574;(IPC1-7):G01N33/574;G01N33/48;G01N33/543 |
主分类号 |
C12N15/02 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|